Previous 10 | Next 10 |
home / stock / bhc:cc / bhc:cc news
LAVAL, QC / ACCESSWIRE / March 1, 2023 / Bausch Health Companies Inc. (TSX:BHC)(NYSE:BHC) today announced that Richard De Schutter and Dr. Argeris Karabelas are retiring from the Company's Board of Directors, effective as of the upcoming 2023 annual meeting of shareholders of the Company. Follow...
Summary Bausch + Lomb Corporation recently appointed a new high-profile CEO in Brent Saunders. Bausch Health Companies Inc. has hit the internal metrics necessary to justify spinning off more Bausch + Lomb shares. The company is counting on significant expenses related to such a tra...
Summary Brent Saunders led Bausch + Lomb Corporation when it was sold to Valeant Pharmaceuticals. He later led and sold competitor Allergan to AbbVie. Brent Saunders likely signed on as CEO with the expectation of operating Bausch + Lomb Corporation as a fully standalone company. ...
The following slide deck was published by Bausch Health Companies Inc. in conjunction with their 2022 Q4 earnings call. For further details see: Bausch Health Companies Inc. 2022 Q4 - Results - Earnings Call Presentation
Bausch Health Companies Inc. (BHC) Q4 2022 Earnings Conference Call February 23, 2023, 08:00 AM ET Company Participants Thomas Appio - Chief Executive Officer Tom Vadaketh - Chief Financial Officer Conference Call Participants Georgi Yordanov - Cowen and Compan...
Bausch Health Companies press release ( NYSE: BHC ): Q4 GAAP EPS of -$1.13. Revenue of $2.2B (flat Y/Y) beats by $60M . Adjusted EBITDAattributable to Bausch Health (non-GAAP)Adjusted EBITDA attributable to Bausch Health (non-GAAP ) 1 was $823 million for the fourth qu...
Fourth-Quarter revenues of $2.2 billion, flat reported, up 4% organic 1 Full-Year revenues of $8.1 billion, down 4% reported, up 2% organic 1 Unrestricted B+L from BHC covenants Reduced debt by $464 million in the fourth quarter Provides 2023 guidance for Bausch Health (excl...
Summary Viatris' gross margin reached its highest level since its inception in the fourth quarter of 2020, despite rising raw material and labor costs. On February 27, 2023, Viatris management will publish financial results for the 4th quarter of 2022. Viatris' operating income for ...
Bausch Health Companies ( NYSE: BHC ) is scheduled to announce Q4 earnings results on Thursday, February 23rd, before market open. The consensus EPS Estimate is $0.95 (+400.0% Y/Y) and the consensus Revenue Estimate is $2.14B (-2.7% Y/Y). Over the last 1 year, BHC has beaten...
Salix to Provide Scholarships to 10 Students Living with GI Diseases LAVAL, QC / ACCESSWIRE / February 13, 2023 / Bausch Health Companies Inc. (NYSE/TSX:BHC) today announced the opening of the 2023 Salix Gastrointestinal Health Scholars Program application period. The program will award 10 e...
News, Short Squeeze, Breakout and More Instantly...
Bausch Health Companies Inc. Company Name:
BHC:CC Stock Symbol:
TSXC Market:
Bausch Health Companies Inc. Website:
LAVAL, QC / ACCESSWIRE / July 19, 2024 / Bausch Health Companies Inc. (NYSE:BHC)(TSX:BHC) today announced the appointment of two new members to its Executive Leadership Team (ELT). Jean-Jacques Charhon ("JJ") will join the Company as Chief Financial Officer on August 19, 2024. JJ has over 25 ...
LAVAL, QC / ACCESSWIRE / July 11, 2024 / Bausch Health Companies Inc. (NYSE:BHC)(TSX:BHC) will release second quarter 2024 financial results on Thursday, August 1, 2024. Bausch Health will host a conference call and live webcast at 8:00 a.m. U.S. EST to discuss the results and provide a business...
The S&P 500 rose to a new high on Friday, putting the broad-market index on track for yet another weekly gain during the holiday-shortened trading week. The tech-heavy NASDAQ Composite also hit a new high. The Dow Jones Industrials climbed 67.87 points to end Friday at 39,375.87. The ...